2025 Precision Medicine Genomics Specialist Intern

Company Description

AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas immunology, oncology, neuroscience, and eye care and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us atwww.abbvie.com. Follow @abbvie onTwitter,Facebook,Instagram,YouTubeandLinkedIn.

Job Description

Precision Medicine Genomics Specialist Intern Overview

Envision spending your summer working with energetic colleagues and inspirational leaders, all while gaining world-class experience in one of the most dynamic organizations in the pharmaceutical industry. This is a reality for AbbVie Interns.

AbbVie's Precision Medicine organization (PMed) is dedicated to advancing translational research and clinical biomarker strategies. Our Translational Research Genomics group in the Precision Medicine Oncology department utilizes advanced single-cell sequencing technologies to study cancer biology, identify biomarkers, and validate mechanisms of action for AbbVie's innovative oncology pipelines. These efforts inform clinical decisions, improve patient outcomes, and enable precise targeting of medicines, identification of combination opportunities, and provision of actionable diagnostic tools to patients and physicians.

We are seeking a motivated and detail-oriented summer intern to join our Precision Medicine Genomics team. The primary focus of this internship will be to contribute to the construction and refinement of an internal single-cell RNAseq or CITEseq database using existing internal data. This is a unique opportunity to gain hands-on experience in translational research and work with cutting-edge technologies and advanced analytics.

This internship will be based in South San Francisco, CA.

Key responsibilities include:

• Build, test, and validate advanced single-cell analysis and annotation pipelines.
• Collate and organize single-cell RNAseq/CITE-Seq data.
• Help construct and refine the internal scRNAseq/CITEseq database and cell annotations.
• Integrate data sets and incorporate multiple layers of cell annotations.
• Perform retrospective analyses of existing datasets and align them with previous analyses and annotation results.
• Ensure the database meets publication standards and internal requirements for cell type classifications.
• Contribute to the development of a dependable and distributable internal baseline reference.

Qualifications

MinimumQualifications

• Currently enrolled in university, pursing a Masters or PhD inBioinformatics, Biology, Biochemistry, Genetics, Computer Biology, Computer Scienceor other related field
• Must be enrolled in university for at least one semester following the internship

Preferred Qualifications

• Expected graduation date between December 2025 July 2026
• Strong understanding of scRNAseq genomics and molecular biology principles
• Proficiency in single-cell RNAseq data analysis using multiple samples
• Proficiency in utilizing R and Python in a Linux environment
• Familiarity with immune cell types and markers
• Ability to work independently and collaborate effectively with a team
• Strong written and verbal communication skills

Benefits and Amenities

• Competitive pay
• Relocation support for eligible students
• Select wellness benefits and paid holiday / sick time
• Opportunity to present the intern project at the end of the program

Equal Employment Opportunity

At AbbVie, we value bringing together individuals from diverse backgrounds to develop new and innovative solutions for patients. As an equal opportunity employer we do not discriminate on the basis of race, color, religion, national origin, age, sex (including pregnancy), physical or mental disability, medical condition, genetic information gender identity or expression, sexual orientation, marital status, protected veteran status, or any other legally protected characteristic.

Additional Information

Applicable only to applicants applying to a position in any location with pay disclosure requirements under state or local law:

• The compensation range described below is the range of possible base pay compensation that the Company believes ingood faith it will pay for this role at the time of this posting based on the job grade for this position. Individualcompensation paid within this range will depend on many factors including geographic location, and we may ultimatelypay more or less than the posted range. This range may be modified in the future.

Note: No amount of payis considered to bewages or compensation until such amount is earned, vested, and determinable.The amount and availability of any bonus, commission, incentive, benefits, or any other form of compensation and benefitsthat are allocable to a particular employee remains in the Company's sole and absolute discretion unless and until paid andmay be modified at the Companys sole and absolute discretion, consistent with applicable law.

AbbVie is an equal opportunity employer and is committed to operating with integrity, driving innovation, transforming lives, serving our community and embracing diversity and inclusion. It is AbbVies policy to employ qualified persons of the greatest ability without discrimination against any employee or applicant for employment because of race, color, religion, national origin, age, sex (including pregnancy), physical or mental disability, medical condition, genetic information, gender identity or expression, sexual orientation, marital status, status as a protected veteran, or any other legally protected group status.

US & Puerto Rico only - to learn more, visithttps://www.abbvie.com/join-us/equal-employment-opportunity-employer.html

US & Puerto Rico applicants seeking a reasonable accommodation, click here to learn more:

https://www.abbvie.com/join-us/reasonable-accommodations.html

Location: South San Francisco, CA, US

Posted Date: 10/27/2024